[go: up one dir, main page]

DK2628754T3 - Fremgangsmåde til fremstilling og anvendelse af en copolymer af natriumcarboxymethylcellulose og gossypol - Google Patents

Fremgangsmåde til fremstilling og anvendelse af en copolymer af natriumcarboxymethylcellulose og gossypol

Info

Publication number
DK2628754T3
DK2628754T3 DK11832823.6T DK11832823T DK2628754T3 DK 2628754 T3 DK2628754 T3 DK 2628754T3 DK 11832823 T DK11832823 T DK 11832823T DK 2628754 T3 DK2628754 T3 DK 2628754T3
Authority
DK
Denmark
Prior art keywords
gossypol
copolymer
preparing
carboxymethyl cellulose
sodium carboxymethyl
Prior art date
Application number
DK11832823.6T
Other languages
English (en)
Inventor
Felix Ivanovich Ershov
Vladimir Georgievich Nesterenko
Abdushukur Abdukhalilovich Sarymsakov
Natalya Uryevna Alekseeva
Original Assignee
Llc Nearmedic Plus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Llc Nearmedic Plus filed Critical Llc Nearmedic Plus
Application granted granted Critical
Publication of DK2628754T3 publication Critical patent/DK2628754T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/02Alkyl or cycloalkyl ethers
    • C08B11/04Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/10Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals
    • C08B11/12Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals substituted with acid radicals substituted with carboxylic radicals, e.g. carboxymethylcellulose [CMC]
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/02Oxycellulose; Hydrocellulose; Cellulosehydrate, e.g. microcrystalline cellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
DK11832823.6T 2010-10-11 2011-10-06 Fremgangsmåde til fremstilling og anvendelse af en copolymer af natriumcarboxymethylcellulose og gossypol DK2628754T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2010141697/05A RU2453559C1 (ru) 2010-10-11 2010-10-11 Способ получения сополимера натрийкарбоксиметилцеллюлозы и госсипола и его применение в комплексной терапии пациентов с аутистическими расстройствами и когнитивными нарушениями
PCT/RU2011/000785 WO2012050483A1 (ru) 2010-10-11 2011-10-06 Способ получения и применение сополимера натрийкарбоксиметилцеллюлозы и госсипола

Publications (1)

Publication Number Publication Date
DK2628754T3 true DK2628754T3 (da) 2017-11-20

Family

ID=45938511

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11832823.6T DK2628754T3 (da) 2010-10-11 2011-10-06 Fremgangsmåde til fremstilling og anvendelse af en copolymer af natriumcarboxymethylcellulose og gossypol

Country Status (27)

Country Link
US (1) US9078916B2 (da)
EP (1) EP2628754B8 (da)
JP (1) JP5690944B2 (da)
CN (1) CN103189393B (da)
AU (1) AU2011314406B2 (da)
BR (1) BR112013008888B1 (da)
CA (2) CA2811583C (da)
CL (2) CL2013000962A1 (da)
CO (1) CO6731081A2 (da)
CY (1) CY1119413T1 (da)
DK (1) DK2628754T3 (da)
EA (2) EA024810B1 (da)
EC (1) ECSP13012613A (da)
ES (1) ES2643167T3 (da)
GE (1) GEP201706607B (da)
HR (1) HRP20171330T1 (da)
HU (1) HUE034920T2 (da)
LT (1) LT2628754T (da)
PE (1) PE20140200A1 (da)
PL (1) PL2628754T3 (da)
PT (1) PT2628754T (da)
RS (1) RS56257B1 (da)
RU (1) RU2453559C1 (da)
SI (1) SI2628754T1 (da)
SM (1) SMT201700497T1 (da)
UA (2) UA108126C2 (da)
WO (1) WO2012050483A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2499002C1 (ru) * 2012-06-14 2013-11-20 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Конъюгаты госсипола и натрийкарбоксиметилцеллюлозы, способы их получения и противовирусные средства на их основе
RU2577539C2 (ru) * 2014-06-17 2016-03-20 Общество С Ограниченной Ответственностью "Ниармедик Плюс" Полимерные производные госсипола, способ их получения и фармацевтическая композиция на их основе
RU2754067C2 (ru) * 2018-05-18 2021-08-25 Общество с ограниченной ответственностью "НИАРМЕДИК ФАРМА" Противомикробная композиция на основе полифенолов и полисахаридов, способ ее получения и применение
RU2746504C1 (ru) * 2020-02-27 2021-04-14 Ниармедик Интернэшнл Лимитед Противомикробные средства на основе бета-глюканов, способы их получения и применения
CN114622407B (zh) * 2022-04-01 2023-09-19 浙江隆腾医用新材料有限公司 一种羧甲基纤维素钠纤维的洗脱方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2002755C1 (ru) * 1991-02-04 1993-11-15 Научно-исследовательский институт эпидемиологии и микробиологии им.Н.Ф.Гамалеи РАМН Производное целлюлозы и госсипола, обладающее интерферониндуцирующим и противовирусным действием
RU2222548C2 (ru) * 2000-07-21 2004-01-27 Зао "Ниармедик Плюс" Применение производного целлюлозы и госсипола в качестве радиопротекторного, противоинфекционного и потенциирующего средства, усовершенствованный способ его получения и фармацевтическая композиция на его основе
US7001920B2 (en) * 2002-06-10 2006-02-21 Wyeth Formate salt of O-desmethyl-venlafaxine
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
RU2238122C1 (ru) * 2003-01-20 2004-10-20 Ооо "Ниармедик Плюс" Противоинфекционный фармацевтический препарат
RU2270708C1 (ru) * 2004-05-26 2006-02-27 Ооо "Ниармедик Плюс" Натриевая соль сополимера карбоксиметилцеллюлозы и госсипола, фармацевтическая композиция и способ профилактики или лечения вирусных заболеваний
US20060144723A1 (en) * 2004-11-02 2006-07-06 Mary Fuller Device for securing valuables
US20070148238A1 (en) * 2005-06-23 2007-06-28 Spherics, Inc. Dosage forms for movement disorder treatment
US20090285865A1 (en) * 2008-05-14 2009-11-19 Shalaby Shalaby W Palatable, solid oral formulations for male chemical sterilization

Also Published As

Publication number Publication date
EP2628754B8 (en) 2017-10-25
US9078916B2 (en) 2015-07-14
UA108975C2 (uk) 2015-06-25
CN103189393A (zh) 2013-07-03
AU2011314406A1 (en) 2013-05-23
EA024810B1 (ru) 2016-10-31
AU2011314406B2 (en) 2016-08-11
LT2628754T (lt) 2017-11-10
PE20140200A1 (es) 2014-02-21
RU2453559C1 (ru) 2012-06-20
HRP20171330T1 (hr) 2017-10-20
CO6731081A2 (es) 2013-08-15
ECSP13012613A (es) 2013-10-31
CL2015001180A1 (es) 2015-08-28
PL2628754T3 (pl) 2017-12-29
US20130266534A1 (en) 2013-10-10
SMT201700497T1 (it) 2017-11-15
CL2013000962A1 (es) 2013-12-06
JP5690944B2 (ja) 2015-03-25
BR112013008888B1 (pt) 2021-01-05
GEP201706607B (en) 2017-01-25
CY1119413T1 (el) 2018-03-07
JP2013540866A (ja) 2013-11-07
EA031316B1 (ru) 2018-12-28
BR112013008888A2 (pt) 2016-06-28
EP2628754A4 (en) 2014-03-26
EA201390530A1 (ru) 2013-07-30
EP2628754B1 (en) 2017-07-12
CA2896450A1 (en) 2012-04-19
CN103189393B (zh) 2015-09-30
EA201690544A1 (ru) 2016-07-29
HUE034920T2 (en) 2018-03-28
PT2628754T (pt) 2017-10-19
SI2628754T1 (en) 2017-11-30
UA108126C2 (uk) 2015-03-25
RS56257B1 (sr) 2017-11-30
WO2012050483A1 (ru) 2012-04-19
RU2010141697A (ru) 2012-04-20
ES2643167T3 (es) 2017-11-21
CA2811583A1 (en) 2012-04-19
CA2811583C (en) 2016-03-22
EP2628754A1 (en) 2013-08-21

Similar Documents

Publication Publication Date Title
CY2020008I1 (el) Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
AP2925A (en) Inhibitors of human immunodeficiency virus replication
PL2627675T3 (pl) Nowe etery celulozy i ich zastosowanie
DK2498756T3 (da) Tabletformuleringer af neratinibmaleat
DK2649812T3 (da) Høreapparat og en fremgangsmåde til at forbedre talegengivelse
BRPI1013622A2 (pt) cápsula liberadora
HUE052617T2 (hu) Oligoszacharid és eljárás elõállítására
FI20095140A0 (fi) Menetelmä muokatun selluloosan valmistamiseksi
DK2857401T3 (da) Hidtil ukendt -lactamaseinhibitor og fremgangsmåde til at fremstille samme
DK2429486T3 (da) Fremgangsmåde til fremstilling af en tværbundet gel
DK3202460T3 (da) Arylmethoxy-isoindolinderivater og sammensætninger omfattende og fremgangsmåder til anvendelser af samme
HRP20160868T1 (hr) Postupak za pripremanje hidromagnezita
EP2433196A4 (en) SYNCHRONOUS NETWORK OF SUPERSPEED AND NON-SUPERSPEED USB DEVICES
DK2414531T3 (da) Forbedret biomasseforbehandlingsproces
DK3382015T3 (da) Fremgangsmåder og produkter til fremstilling af voksestere
HRP20150072T1 (xx) Agomelatin halogenovodik kompleks i postupak njegove priprave
DK2794850T3 (da) Bioteknologisk produktion af alkoholer og derivater deraf
HUE036576T2 (hu) Módszer és készítmény a megtermékenyítés idejének szinkronizálására
ZA201409007B (en) High water content oral compositions comprising microcrystalline cellulose and carboxymethylcellulose
DK3095441T3 (da) Hurtigt opløsende doseringsform af en oral vaccine under anvendelse af stivelse
DK2646452T3 (da) Chlorering af carbohydrater og carbohydratderivater
DOP2012000278A (es) Tableta enterica
BR112012002971A2 (pt) preparação regioseletiva de derivados 2-amino-5-trifluorometil-pirmidinas
BR112012000455A2 (pt) oclusor
DK2628754T3 (da) Fremgangsmåde til fremstilling og anvendelse af en copolymer af natriumcarboxymethylcellulose og gossypol